secwatch.observer — SEC 8-K summary
======================================

Issuer:     CV Sciences, Inc. (CVSI)
CIK:        0001510964
Form:       8-K
Filed at:   2025-05-14T23:59:59+00:00
Accession:  0000950170-25-071347
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CV Sciences Q1 2025 revenue $3.6M (-10% YoY); turns operating profit $11K
-------------------------------------------------------------------------

- Q1 revenue $3.6M vs $4.0M YoY; unit volume down 11.8%, partially offset by 0.9% price increase.
- Operating income of $11K vs $0.6M loss YoY, boosted by $0.5M reversal of accrued payroll taxes.
- Adjusted EBITDA loss improved to $0.3M from $0.5M YoY; gross margin 46.0% vs 46.3%.
- Launched Lunar Fox plant-based product line with 7 vegan products in U.S. retail and online.
- Raised $1.2M net from institutional investor in Q1; cash balance $0.8M vs $0.5M end-2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1510964/000095017025071347/0000950170-25-071347-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1510964/000095017025071347/cvsi-20250514.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-071347

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer